Skip to main content

Lyme Disease Science Articles

Explore our comprehensive collection of evidence-based articles about Lyme disease, covering symptoms, diagnosis, treatment, and the latest research findings. All content reviewed by medical experts.

Evidence-Based Research and Information in French

Browse all our science articles below. Each article is thoroughly researched and referenced from peer-reviewed medical literature.

This article explores the ecology and epidemiology of Borrelia miyamotoi and Borrelia mayonii, highlighting their unique transmission dynamics, genetic diversity, and emerging status as tick-borne pathogens.

Borrelia afzelii is a leading cause of Lyme borreliosis in Europe and Asia, transmitted by ticks and primarily adapted to rodent hosts. This bacterium is linked to chronic skin conditions, arthritis, and evades immune responses through antigenic variation.

Borrelia garinii, a key Lyme disease pathogen in Eurasia, is linked to neurological complications in humans. Known for its association with bird hosts, it has also been recently discovered in isolated areas of North America.

Borrelia's outer surface proteins (Osps) are key to the bacterium's ability to infect and persist within hosts. This detailed exploration covers how Osps facilitate immune evasion, biofilm formation, and tissue colonization. It also examines groundbreaking therapeutic approaches such as monoclonal antibodies and biofilm-disrupting treatments, offering new insights into more effective treatment for both acute and chronic Lyme disease.

Borrelia species infections, such as Lyme Disease, present a variety of clinical manifestations. This article explores the range of symptoms across different Borrelial illnesses, helping to identify and differentiate these infections based on their unique clinical profiles.

Latest Publications

Case Studies

×

Nouvelles approches pour la maladie de Lyme : des résultats concrets

Profitez des analyses les plus récentes pour obtenir une guérison complète et durable.

Débloquer l'accès